Higher Crohn's disease rates with vedolizumab: a study

Published Date: 13 Mar 2023

The study results may prompt doctors to choose vedolizumab over anti-TNF therapy as the first-line treatment for Crohn's disease.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

2.

Maintenance Rituximab Improves Survival in Elderly MRD-Negative MCL Patients.

3.

Patient Endured 9 Years of Chemotherapy for Cancer He Never Had

4.

Cancer patients with HIV have demonstrated safety with immune checkpoint inhibitors.

5.

Cancerous breast tissue glows in new AI-enhanced MRI images


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot